Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Serotonin Receptors Affect Reaction to Stress

By HospiMedica staff writers
Posted on 05 Dec 2005
How individuals react to stressful situations and difficult situation could be partly caused by the dominance of one cell-surface marker over another in a brain region involved in controlling emotional responses and behaviors, suggest findings from a new study.

The study was performed by scientists from the University of Pittsburgh (PA, USA). More...
These two markers--both receptors that determine what effect the neurotransmitter serotonin has on a neuron--seem to be major intermediaries influencing emotional state and behavior during stress.

In a localized region of the prefrontal cortex, where thought and action are organized, the number and ratio of serotonin receptors were discovered to be directly associated with the activity of another part of the brain called the amygdala, which is vital for producing emotional states such as fear. According to Ahmad Hariri, Ph.D., who led the study, these findings bring understanding into what could be a essential factor contributing to the development of risk for psychiatric disorders and a significant molecular mechanism to target as new therapies are developed.

The subgenual prefrontal cortex is one region where communication, or cross talk, occurs between the impulsive, reflexive amygdala, and the more logical, serious prefrontal cortex. The study of 18 normal people utilized positron emission tomography (PET), which provides three-dimensional (3D) detail of the distribution of molecular structures. The investigators used PET to assess the availability of the two receptors for serotonin in specific areas of the participants' brains, including the amygdala and subgenual prefrontal cortex. One of these receptors, the 5-HT1A, causes neurons to be inhibited when serotonin binds to it. In contrast, binding the other receptor, the 5-HT2A, causes the cell to be excited.

The same individuals also underwent testing with functional magnetic resonance imaging (fMRI), which illustrates the regions of the brain that are engaged during different tasks. Those individuals in whom PET showed a higher number of serotonin 5-HT1A receptors relative to 5-HT2A receptors in the subgenual prefrontal cortex had less brain activity in this area during fMRI, as would be expected, because 5-HT1A is the inhibitory receptor. The scientists discovered that these specific serotonin receptors seem to help control the extent to which any rational communication takes place in the subgenual prefrontal cortex. Without the voice of reason, the amygdala can act as it chooses.

By evaluating individuals who carry a form of a gene required for determining expression of the serotonin transporter and who, because of this variation, are more susceptible to develop depression when confronted with stressful and difficult life situations, the researchers found less crosstalk in the subgenual prefrontal cortex as well as greater amygdala activity.




Related Links:
University of Pittsburgh

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.